Specific Biologics

Specific Biologics is a biotech company in Toronto, Canada, founded in 2017. It has raised $35.0M across 1 round, most recently a $35.0M Series A in November 2026.

Headquarters
Toronto, Ontario
Employees
1–10
Founded
2017
Total Funding
$35.0M
Last Round
$35.0M Series ANov 2026
Rounds
1

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 1 funding round for this company. The full record is or through the API.

About

Specific Biologics develops Dualase genome editors as potential medicines for genetic diseases. Its two-site editing mechanism enables removal, repair, and insertion of small or large sequences. Its therapeutic pipeline targets central nervous system, lung, and liver indications, with an initial focus on precisely removing expanded DNA repeats and correcting underlying genetic drivers of disease.

Summary

It lists 1–10 employees. It has raised $35.0M in total across 1 round, most recently a $35.0M Series A round in Nov 2026.

Funding History

Data from Indexed.vcUpdated
Series ASeries ANov 2026
$35.0M

Similar Companies

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
ParexelAcquired

One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...

Raleigh, United States10001+Biotech
Private EquityTotal funding$5.0BJun 2017
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Specific Biologics on Indexed.vc
<a href="https://indexed.vc/companies/specific-biologics"><img src="https://indexed.vc/api/badge/company/specific-biologics" alt="Specific Biologics on Indexed.vc" width="260" height="76" /></a>